|
|
Michael Murphy, PhD - Research Director, Biology |
|
Dr Murphy is group leader, mitochondrial dysfunction, MRC Dunn Human Nutrition Unit, Hills Road Cambridge, UK. He obtained an honors degree in Chemistry from Trinity College Dublin and a PhD in biochemistry from University of Cambridge. He held research and teaching appointments at Columbia University, New York, Trinity College, Dublin and University of Otago, Dunedin. He was a visiting professor at the Biozentrum, University of Basel, Switzerland and the University of Alabama, Birmingham before being appointed associate dean for research at Otago University School of Medical Sciences. In 2001 his research group moved to the MRC Dunn Human Nutrition Unit. Dr Murphy's research investigates how mitochondrial damage contributes to human diseases. |
|
|
Robin Smith, PhD - Research Director, Chemistry |
|
Dr Smith is Professor of Chemistry, University of Otago, an elected Fellow of the Royal Society of New Zealand, a Fellow of the New Zealand Institute of Chemistry and a Member of the Royal Society of Chemistry. After graduating from University of Otago with an honors degree and PhD in chemistry, he held academic research appointments in chemistry at Indiana University and Dartmouth College. Since 1971 he has been a faculty member of the Chemistry Department, University of Otago, Dunedin, New Zealand and has held Visiting Fellowships the Institut de Chimie des Substances Naturelles, Gif-sur-Yvette, France, Research School of Chemistry, Australian National University, Canberra, Australia and Department of Organic Chemistry, Bell Laboratories, AT & T, New Jersey. He has also held Visiting Professorships at the University of California, Santa Barbara and the University of Utah. His research area is synthetic organic chemistry with application to biological systems. Professor Smith directs the Antipodean Pharmaceuticals scientific team at Otago University which includes chemists, biochemists and pharmaceutical scientists. |
|
|
